Working to Eradicate Gynecologic Cancers

Hye Sook Chon, MD

Assistant Member
H. Lee Moffitt Cancer Center
12902 Magnolia drive suite 3057H
Tampa, FL
USA 33612


Biographical Sketch:
ASCO poster presentation 2012 SGO plenary session 2010 Chon HS et al. The BCL2 Antagonist of Cell Death (BAD) pathway influences endometrial cancer cell sensitivity to cisplatin. Gynecol Oncol. 2012 Jan;124(1):119-24. Chon HS et al. Targeted therapy in gynecologic cancers. Current Cancer Drug Targets. 2006; 6(4);333-363

Papers:
250 Therapeutic dilemma: prognostic factors and outcome for patients with neuroendocrine tumors of the cervix 361 The BAD apoptotic pathway: a cervical cancer therapeutic target associated with disease development, therapeutic response and patient survival 422 The impact of depression on survival in uterine carcinosarcoma